Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

Bullboard Posts

Post by laroplexon Sep 08, 2016 8:39am

126 Views

Post# 25216916

More buying on the Open market!!

Stifano keeps plugging away at it......a little here and there accumulates quite a bit down the road......GLTA

test 10 SEDI filings (by transaction date) for LBL within the last 6 months

	?
Amended Filing

					As of 11:59pm ET September 7th, 2016
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Sep 7/16	Sep 7/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	3,800	$0.245
Aug 19/16	Aug 19/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	5,200	$0.860
Aug 19/16	Aug 18/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	2,000	$0.280
Aug 18/16	Aug 17/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	2,000	$0.280
Aug 8/16	Aug 8/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	2,000	$0.270
Aug 8/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Disposition in the public market	-500	$0.260
Aug 8/16	Aug 8/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	1,900	$0.260
Jul 15/16	Jul 14/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	$0.180
Jun 27/16	Jun 27/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	15,600	$0.185
Jun 27/16	Jun 27/16	Stifano, Mario	Direct Ownership	Common Shares	10 - Acquisition in the public market	2,000	$0.160